Bleeding gums? Don't ignore the warning signs – the first stage of gum disease can be reversed
26.10.2026 11:28:00 CET | Business Wire | Press release
Oral-B iO helps you avoid new tooth and gum issues—and if you have existing gum problems, it can resolve them quicker than a manual toothbrush.
Gums bleeding when brushing can happen to any of us, and it is easy to ignore. But blood in the sink is a sign that something is not right with your mouth. Bleeding gums often indicate gingivitis, the earliest and most common form of gum disease. The good news: gingivitis can be reversed with proper oral hygiene.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022835650/en/

Oral-B iO
Left untreated, gingivitis can progress into periodontitis, a more severe stage of gum disease that can only be managed, not reversed, and can lead to losing teeth over time. Healthy gums matter beyond the mouth, too. Oral health and systemic health are deeply interconnected, with inflammation and bacteria from oral diseases contributing to conditions such as heart disease, diabetes and dementia.
"Gums bleeding when brushing can happen to any of us. When they do, it shouldn't be ignored," said Eva Castro Perea, who holds a degree in dentistry and is Senior Scientific Relations Manager for Oral-B in the UK. "The worst thing you can do is nothing. Gingivitis can be reversed with proper oral hygiene, but periodontitis can only be managed. If your gums don't improve within two weeks, see your dentist or dental hygienist."
Why do my gums bleed when I brush or floss?
Bleeding when brushing or flossing often indicates gingivitis, an inflammation of the gum tissue typically caused by a buildup of plaque. Bacteria in plaque irritate the gums, making them red, swollen and prone to bleeding.
However, gum disease is not the only possible cause. Bleeding gums can also be associated with aggressive brushing (brushing too hard or with stiff bristles can also damage delicate gum tissue), hormonal changes, vitamin deficiencies, certain medications, diabetes, smoking, ill-fitting dentures and blood-clotting disorders.
Should I stop flossing if my gums bleed?
No. Bleeding when flossing is often a sign of inflammation, and continuing to floss gently can help reduce it and improve gum health. Avoiding flossing can lead to more plaque buildup, making the problem worse.
What's the difference between gingivitis and periodontitis?
| Gingivitis | Periodontitis |
Stage | First stage of gum disease | More severe, advanced stage of gum disease |
Reversible? | Yes, with proper oral hygiene | No, it can only be managed and treated |
Signs | Swollen, red or bleeding gums | Bleeding, receding gums, loose teeth |
When should I see a dentist?
Occasional gum bleeding is not uncommon, but frequent, persistent or heavy bleeding should be taken seriously. If the bleeding persists, worsens or does not improve, consult a dentist or dental hygienist. They can assess your oral health, examine your gums, identify underlying issues that may be causing the bleeding, and recommend appropriate treatment options.
Is an electric toothbrush better for gum health than a manual one?
Yes. Electric toothbrushing has been scientifically proven to make a noticeable difference in your oral health, compared to using a manual toothbrush. Oral-B iO helps you avoid new tooth and gum issues, and if you have existing gingivitis, it can resolve it quicker than a manual toothbrush. Pair Oral-B toothpaste with an Oral-B iO electric toothbrush to help stop bleeding and reverse signs of early gum disease. Its gentle micro-vibrations and smart pressure sensor help you deliver an effective clean while protecting your gums.
When you brush with Oral-B iO, you can protect your gums and help prevent future gum recession. A study found that for subjects susceptible to gingival recession, an electric toothbrush was a safe option over 36 months.¹ Pair it with an advanced brush head, such as the Oral-B iO Gentle Care, designed to deliver an effective yet gentle clean along the gumline. This superior cleaning performance is reflected in multiple independent clinical studies, which show that Oral-B iO provides 100% more plaque removal and 6x more plaque removal along the gumline than a manual toothbrush, together with 14.5x higher odds of moving from non-healthy to healthy gums compared to regular manual toothbrush users.
Can toothpaste help treat early gum disease, or only prevent it?
Both. Toothpastes containing stannous fluoride, such as Oral-B Pro-Expert, are specially formulated to target and neutralise the harmful plaque bacteria that build up around the gumline, helping to treat and prevent gingivitis. Complete the routine with daily flossing and Oral-B Mouthwash, clinically proven to provide 24-hour protection against plaque and gingivitis with twice-daily use.
1. | Sutor, S., et al. (2025). Effect of a powered and a manual toothbrush in subjects susceptible to gingival recession: a 36-month randomized controlled clinical study. International Journal of Dental Hygiene, 23(1), 26–36. |
About Oral-B
Oral-B® was founded in 1950 by a California periodontist, who invented an innovative toothbrush to help his patients achieve healthier teeth and gums at home. Oral-B® continues to stay true to his mission and is today the worldwide leader in the over $5 billion brushing market. Part of the Procter & Gamble Company, the brand manufactures electric toothbrushes and toothpaste for adults and children, oral irrigators, and interdental products.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261022835650/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Highlights New Data Advancing its Gastrointestinal Cancer Portfolio at ESMO 202626.10.2026 14:45:00 CET | Press release
INCB161734 (KRAS G12D inhibitor) and INCA338901 (TGFβR2×PD-1 bispecific antibody) data reinforce ongoing and planned registrational trials, including DAWN-303 in pancreatic ductal adenocarcinoma (PDAC) and NEXERA-303 in colorectal cancer (CRC), respectivelyNew data evaluating INCB161734 in CRC highlight its clinical activity across KRAS G12D-mutated tumor types and support initiation of a Phase 3 study in second-line CRC planned for 2027INCB161734 and INCA33890 demonstrated manageable safety profiles in combination with standard-of-care (SoC) chemotherapiesNew collaborations with Bristol Myers Squibb and Synnovation in PDAC to evaluate INCB161734 in combination with navlimetostat, an MTA-cooperative PRMT5 inhibitor, and SNV1521, a PARP1 inhibitor, respectivelyThese results and additional updates will be presented at an analyst and investor event on Monday, October 26, 2026, from 7:30 – 9:00 p.m. CET (2:30 – 4:00 p.m. EDT) Incyte (Nasdaq:INCY) announced new results from its advancing on
Bending Spoons Completes the Acquisition of Miro26.10.2026 14:00:00 CET | Press release
Bending Spoons S.p.A. (NASDAQ: BSP) has completed the previously announced acquisition of Miro, the visual collaboration platform used by more than 250,000 organizations to brainstorm, plan, and build together. “Miro has built a strong business around a product that makes complex collaborative work feel simple,” said Luca Ferrari, Bending Spoons CEO and co-founder. “Miro’s versatility has made it useful across a broad range of industries and workflows, while creating a robust foundation for further expansion. We believe there’s significant potential to build on these strengths. We look forward to drawing on Bending Spoons’ technologies and expertise to make Miro even more useful to customers and support its continued growth.” “Teams depend on Miro for innovating, alignment, coordination, and decisioning, and that need is only growing,“ said Andrey Khusid, CEO and co-founder of Miro. “In Bending Spoons, Miro has an owner who invests for the long term and cares deeply about product quali
Dubai Culture Opens Registration for ISEA2026 Dubai26.10.2026 13:09:00 CET | Press release
Dubai Culture and Arts Authority (Dubai Culture) has opened registration for the 31st International Symposium on Electronic/Emerging Art (ISEA2026 Dubai), taking place from 6 to 15 November 2026 under the theme ‘ELYAH: Constellating Place, Data and Identity’. The symposium will be the largest edition to date, bringing together artists, researchers, and innovators from around the world to explore the intersection of art, science, and technology and exchange perspectives on the future of contemporary creative practice. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261026652826/en/ Dubai Culture Opens Registration for ISEA2026 Dubai (Graphic: AETOSWire) The event supports Dubai Culture’s efforts to advance the digital arts ecosystem, deliver on its Digital Arts Roadmap objectives, and empower local talent. It also reinforces Dubai’s position as a global cultural reference, a leader in innovation, a driver of the creative econo
Agendia Unveils Clinical Validation of AI-Driven Digital Pathology Approach26.10.2026 13:00:00 CET | Press release
The investigational AI-driven digital assay demonstrated high concordance with MammaPrint results in the prospective RASTER cohort of 372 early-stage breast cancer patients with a median follow-up of 10.3 years Agendia, Inc., a leader in precision oncology for breast cancer, recently presented research introducing its investigational artificial intelligence (AI)-driven digital pathology approach for the MammaPrint®70-gene recurrence signature at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid. The podium presentation, delivered by co-founder and Chief Research Officer, Laura van ’t Veer, Ph.D., detailed the development and clinical validation of a deep learning pipeline that can infer MammaPrint (MP) risk categories directly from hematoxylin and eosin (H&E)-stained, whole-slide images (WSIs). The company also presented two additional posters highlighting data from the prospective, real-world FLEX Study (NCT03053193). “AI has been part of Agendia’s scientific fo
C.H. Robinson Debuts Lean AI for Ocean Shipping, Air Freight and Customs26.10.2026 13:00:00 CET | Press release
Global logistic provider’s fleet of AI agents grows, bringing greater speed, precision and agility to supply chains around the world As the global leader in Lean AI, C.H. Robinson has launched new AI agents that perform work in ocean shipping, air freight and customs brokerage. They represent an expansion of the company’s Lean AI capabilities into freight forwarding, for the benefit of more customers, and into work so complex that a single shipping task can require over a dozen AI agents working in tandem. Continuing to disrupt itself and the industry, the company’s new tech brings substantial speed-to-market gains, precision and agility to customers’ supply chains without sacrificing human oversight or personal attention. The new tech includes: Price-quoting for ocean and air cargo: AI has determined and delivered over 80,000 price quotes for over 3,600 customers. Quotes that used to take a day for an air shipment and two to three days for an ocean shipment now take two to three minut
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom